Connect with us

health

Nigeria records 8,439 COVID-19 vaccine’s adverse reactions – NPHCDA

Published

Eti Osa, Mainland, Ikeja, most vaccinated LGAs in Lagos - Commissioner

The National Primary Health Care Development Agency on Friday  disclosed that Nigeria recorded 8,439 mild adverse events at the nationwide COVID-19 vaccination which commenced on March 15, 2021.

NPHCDA Executive Director, Dr. Faisal Shuaib  disclosed this at the joint press conference organised by the agency in collaboration with the World Health Organisation to update Nigerians on the status of the COVID-19 vaccination campaign.

He said five states have the highest records of the AEFI namely: Kaduna (970) Cross River (859), Yobe (541), Kebbi (511), and Lagos (448).

MORE READING!  Resident doctors agree to shelve planned strike - Gbajabiamila

The NPHCDA boss however said the country had not recorded any death or case of blood clots related to the administration of the vaccine.

He said, “In Nigeria, since the vaccination programme was officially rolled out on April 15, 2021, a total of 8,439 mild Adverse Events Following Immunisation have been reported.

MORE READING!  Resident doctors agree to shelve planned strike - Gbajabiamila

People willing to get COVID-19 vaccine declined, says NBS

Nigeria making progress on COVID-19 vaccine, rapid testing kits – Buhari

“These range from pain, swelling at the site of the inoculation, to body pains and nausea. Similarly, 52 cases of moderate to severe incidents of AEFI have been reported.

“These presented as fever, vomiting, diarrhea headaches, dizziness, and allergic reactions. Five states have the highest records of the AEFI namely: Kaduna (970) Cross River (859), Yobe (541), Kebbi (511), and Lagos (448).

MORE READING!  Resident doctors agree to shelve planned strike - Gbajabiamila

“There has been no death from the administration of the vaccine. We have also not diagnosed any case of blood clots related to the administration of the vaccines.

“Nevertheless, we are working with NAFDAC, NCDC, and other relevant agencies to set up a more active surveillance system built on our experience with polio surveillance.”

Advertisement
Comments




Trending